Skip to main content
Clinical Trials/NCT04233320
NCT04233320
Unknown
Not Applicable

Efficacy and Safety of Silicone Cream Containing Allium Cepa Extract in Post-cesarean Surgical Scars Treatment

Chulalongkorn University0 sites22 target enrollmentFebruary 1, 2020
ConditionsCicatrix

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cicatrix
Sponsor
Chulalongkorn University
Enrollment
22
Primary Endpoint
Patient and Observer Scar Assessment Scale
Last Updated
6 years ago

Overview

Brief Summary

The objectives of this study were to evaluate efficacy and safety of silicone cream containing Allium Cepa extract in post-cesarean surgical scars treatment. Post-cesarean surgical scars were equally seperated into 2 parts (left part and right part). Silicone cream containing Allium Cepa extract or commercial scar gel was ramdomly assigned to apply on left part or right part of the scar. They will be applied 2 times per day (morning and evening) for 3 months. Patient and Observer Scar Assessment Scale (POSAS) , Vancouver scar scale (VSS), melanin index, and erythema index (using cutometer) were used for scar evaluation at 0, 1,2,and 3 months. Moreover, adverse effects were also observed.

Registry
clinicaltrials.gov
Start Date
February 1, 2020
End Date
September 30, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Pornanong Aramwit, Pharm.D., Ph.D

Professor

Chulalongkorn University

Eligibility Criteria

Inclusion Criteria

  • Age 18-40 years
  • Have Post-Cesarean Surgical Scars at least 1 month
  • REEDA scale = 0 score
  • Able to read and write Thai
  • Able to follow the research plan
  • Able to meet all the researchers throughout the period of participation in the project

Exclusion Criteria

  • Apply other topical application at the post-cesarean surgical scars within 2 weeks before participating in the study and during the study
  • There is radiation in the area of the post-cesarean surgical scars
  • Chronic skin diseases such as psoriasis, chronic dermatitis, allergies
  • Immune deficient or use immunosuppressants within 2 weeks before participating in the study and during the study
  • Have a history of silicone allergy or onion extract

Outcomes

Primary Outcomes

Patient and Observer Scar Assessment Scale

Time Frame: 3 months

The range of score is 1 to 10. Noraml skin will be recorded as scale 1. Higher scores mean a worse outcome.

Secondary Outcomes

  • Vancouver scar scale(3 months)
  • Melanin index(3 months)
  • Erythema index(3 months)
  • Adverse effect(3 months)

Similar Trials